What's New in GLP-1s?

In this CME, Janet Leung, MD, discusses how to compare FDA-approved GLP-1a (and GIP/GLPa), relative efficacy to each other, and expanded indications. Dr. Leung also details upcoming twin and tricretins therapies that have already made the news, the mechanisms of action, and how that explains side-effect profiles. She also educates on strategies to mitigate, focusing on GI side effects, how to identify concerns for muscle loss, strategies to mitigate, upcoming pharmaceuticals under development, and describes the landscape of coverage, including direct pay.

Educational Objectives 

Upon completion of this activity, participants should be able to:

  • Compare currently FDA approved GLP1a (and GIP/GLPa), relative efficacy to each other, and expanded indications.
  • Discuss upcoming twin and tricretins therapies that have already made the news.
  • Explain the mechanisms of action and how that explains side-effect profiles, and strategies to mitigate, focusing on GI side effects.
  • Identify concerns for muscle loss, strategies to mitigate, and upcoming pharmaceuticals under development.
  • Describe landscape of coverage (including direct pay).

Disclosures:

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated. 

Dr. Leung has a small amount of publicly held stock in Quest and Doximity.

 

Accreditation Statement

Jointly Accredited Provider Mark

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.

Release Date: 11/17/2026 | Last Modified On: 11/17/2026 | Expires: 11/17/2027


Published

November 17, 2026

Expires

November 17, 2027

Related Presenters

Janet Leung, MD

Janet Leung, MD

Clinical Associate Professor of Medicine Associate Program Director and Clinical Lead, Quality Improvement

Full Profile